Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.61 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.54 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.42 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.42 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29795971 | 1.00 | GABRA1 (0.61) | GABRA1GABRB2CYP3A4SIGMAR1GRIN2D | |
| SCHEMBL7001694 | 0.91 | GABRA1 (0.52) | GABRA1GABRB2CYP3A4SIGMAR1GRIN2D | |
| SCHEMBL9623463 | 0.86 | GABRA1 (0.47) | GABRA1GABRB2CYP3A4SIGMAR1GRIN2D | |
| SCHEMBL8943184 | 0.86 | GABRA1 (0.61) | GABRA1GABRB2CYP3A4SIGMAR1GRIN2D | |
| SCHEMBL93143 | 0.86 | GABRA1 (0.50) | GABRA1GABRB2CYP3A4SIGMAR1GRIN2D | |
| SCHEMBL722841 | 0.84 | GABRA1 (0.47) | GABRA1GABRB2CYP3A4SIGMAR1GRIN2D | |
| SCHEMBL18701450 | 0.84 | CYP3A4 (0.50) | GABRA1GABRB2CYP3A4TSHRALDH1A1 | |
| SCHEMBL31109186 | 0.84 | CYP3A4 (0.50) | GABRA1GABRB2CYP3A4TSHRALDH1A1 | |
| SCHEMBL15544 | 0.84 | CYP3A4 (0.50) | GABRA1GABRB2CYP3A4TSHRALDH1A1 | |
| SCHEMBL661906 | 0.84 | CYP3A4 (0.50) | GABRA1GABRB2CYP3A4TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 734 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116396303-B | Gimalane-guaiane sesquiterpene dimer and preparation method and application thereof | 中国科学院昆明植物研究所 | 2025-02-18 | — | — | CN | claimed |
| CN-118184675-A | Mugwort lactone I derivative and pharmaceutical composition thereof, and preparation method and application thereof | 中国科学院昆明植物研究所 | 2024-06-14 | — | — | CN | claimed |
| CN-117621582-B | Layered composite material and preparation method and application thereof | 河北英利奥体育用品有限公司 | 2024-06-11 | — | — | CN | claimed |
| US-20240154124-A1 | NEGATIVE ELECTRODE PLATE AND LITHIUM-ION BATTERY COMPRISING SAME | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2024-05-09 | — | — | US | claimed |
| CN-117964892-A | Modified macromer, preparation method thereof and application thereof in polymer polyol | 中国石油化工股份有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117621582-A | Layered composite material and preparation method and application thereof | 河北英利奥体育用品有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117510429-A | Compound containing methyl isoxazole structure, and preparation method and application thereof | 中国农业大学 | 2024-02-06 | — | — | CN | claimed |
| CN-116396303-A | Gimalane-guaiane sesquiterpene dimer and preparation method and application thereof | 中国科学院昆明植物研究所 | 2023-07-07 | — | — | CN | claimed |
| US-20230151136-A1 | CATALYST COMPOSITION FOR POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-18 | — | — | US | claimed |
| US-20230134280-A1 | CATALYSTS FOR THE FORMATION OF POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-04 | — | — | US | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| US-20040215038-A1 | Colorant precursor compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040215002-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040215022-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040214918-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-6790267-B1 | METHINE COLORANT COMPOUNDS FOR PHASE CHANGE INKS | XEROX CORPORATION | 2004-09-14 | — | — | US | claimed |
| US-20040167249-A1 | Phase change inks with isocyanate-derived antioxidants and UV stabilizers | XEROX CORPORATION | 2004-08-26 | — | — | US | claimed |
| US-6764541-B1 | Colorant compositions | XEROX CORPORATION | 2004-07-20 | — | — | US | claimed |
| US-6652635-B2 | Cyan phase change inks | XEROX CORPORATION | 2003-11-25 | — | — | US | claimed |
| US-20030079645-A1 | Cyan phase change inks | XEROX CORPORATION | 2003-05-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040215022-A1 | Colorant compositions | ARSA, TST, IK | GABRA1 3037/4885GABRB2 3589/4885CYP3A4 974/4885 |
| US-20040215038-A1 | Colorant precursor compositions | RB1, SULT1A1, CBR1 | GABRA1 3481/4885GABRB2 4231/4885CYP3A4 106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.